batiraxcept,nivolumab,cabozantinib
aravive,bms
['cabo ', 'nivo', 'batiraxcept']
ph ii trial of batiraxcept (axl inh) in 3 cohorts
1: batiraxcept only in pts w/ relapsing disease and no other options (n=10)--&gt; orr: 0%
2: batiraxcept + cabo in 2l tx pts (n=25)--&gt; orr: 36%
3: batiraxcept + cabo + nivo in tx naive pts (n=11)
gr3+ aes: 10-46% #asco23 
MD, MSc | @UofTUrology @SUO_YUO Fellow & @IHPMEUofT CEHCR PhD| Previously: @MCG_Urology and @AUB_Lebanon 🇱🇧